key: cord-1056648-sl4oegdv authors: Madewell, Zachary J.; Yang, Yang; Longini, Ira M.; Halloran, M. Elizabeth; Dean, Natalie E. title: Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis date: 2022-04-28 journal: JAMA Netw Open DOI: 10.1001/jamanetworkopen.2022.9317 sha: face146a37fbb6ff11f5f84fb726bc47e7cdd888 doc_id: 1056648 cord_uid: sl4oegdv IMPORTANCE: An overall household secondary attack rate (SAR) of 18.9% (95% CI, 16.2%-22.0%) through June 17, 2021 was previously reported for SARS-CoV-2. Emerging variants of concern and increased vaccination have affected transmission rates. OBJECTIVE: To evaluate how reported household SARs changed over time and whether SARs varied by viral variant and index case and contact vaccination status. DATA SOURCES: PubMed and medRxiv from June 18, 2021, through March 8, 2022, and reference lists of eligible articles. Preprints were included. STUDY SELECTION: Articles with original data reporting the number of infected and total number of household contacts. Search terms included SARS-CoV-2, COVID-19, variant, vaccination, secondary attack rate, secondary infection rate, household, index case, family contacts, close contacts, and family transmission. DATA EXTRACTION AND SYNTHESIS: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guideline was followed. Meta-analyses used generalized linear mixed models to obtain SAR estimates and 95% CIs. MAIN OUTCOMES AND MEASURES: SAR stratified by covariates according to variant, index case and contact vaccination status, and index case identification period. SARs were used to estimate vaccine effectiveness on the basis of the transmission probability for susceptibility to infection (VE(S,p)), infectiousness given infection (VE(I,p)), and total vaccine effectiveness (VE(T,p)). RESULTS: Household SARs were higher for 33 studies with midpoints in 2021 to 2022 (37.3%; 95% CI, 32.7% to 42.1%) compared with 63 studies with midpoints through April 2020 (15.5%; 95% CI, 13.2% to 18.2%). Household SARs were 42.7% (95% CI, 35.4% to 50.4%) for Omicron (7 studies), 36.4% (95% CI, 33.4% to 39.5%) for Alpha (11 studies), 29.7% (95% CI, 23.0% to 37.3%) for Delta (16 studies), and 22.5% (95% CI, 18.6% to 26.8%) for Beta (3 studies). For full vaccination, VE(S,p) was 78.6% (95% CI, 76.0% to 80.9%) for Alpha, 56.4% (95% CI, 54.6% to 58.1%) for Delta, and 18.1% (95% CI, −18.3% to 43.3%) for Omicron; VE(I,p) was 75.3% (95% CI, 69.9% to 79.8%) for Alpha, 21.9% (95% CI, 11.0% to 31.5%) for Delta, and 18.2% (95% CI, 0.6% to 32.6%) for Omicron; and VE(T,p) was 94.7% (95% CI, 93.3% to 95.8%) for Alpha, 64.4% (95% CI, 58.0% to 69.8%) for Delta, and 35.8% (95% CI, 13.0% to 52.6%) for Omicron. CONCLUSIONS AND RELEVANCE: These results suggest that emerging SARS-CoV-2 variants of concern have increased transmissibility. Full vaccination was associated with reductions in susceptibility and infectiousness, but more so for Alpha than Delta and Omicron. The changes in estimated vaccine effectiveness underscore the challenges of developing effective vaccines concomitant with viral evolution. Reports excluded (n = 67): -No data on uninfected contacts (n = 22) -No data on household contacts (n = 19) -Reported prevalence or overall household attack rate, which includes index cases (n = 10) -Tested household contacts using antibody tests (n = 9) -No original data (n = 4) -Overlapping study population with another article included in meta-analysis (n = 2) -Restricted to households with at least one confirmed case among household contacts (n = 1) New studies included (n = 58) Total studies included in review (n = 135) Records identified from reference lists of eligible articles (n = 2) Studies included in previous version of review (n = 87 studies) Reviewed methodology to exclude studies that did not include laboratory-confirmed infections, included asymptomatic index cases only, and were preprints that were subsequently published (n = 87) Records excluded (n = 10) -No lab-confirmed infections (n = 5) -Preprints in first analysis that were subsequently published (n = 4) -Asymptomatic index cases (n = 1) Database Figure 2 when restricting to studies with low risk of bias. Received a booster dose was defined as having received an additional dose after completion of the primary COVID-19 vaccination series before the index date. Fully vaccinated was defined as completion of the primary vaccination series ≥2 weeks before the index date and stratified into completion <5 months or ≥5 months before the index date. Some persons who were fully vaccinated had unknown dates for completion of their primary vaccination series. Partially vaccinated was defined as having only 1 dose of a 2-dose series or completing the primary vaccination series <2 weeks before the index date. De Gier et al. 11 Partly vaccinated was defined as having received the first dose of a two-dose schedule at least 14 days before onset of symptoms. Fully vaccinated was defined as having completed a two-dose schedule at least 7 days or the one-dose Janssen schedule at least 14 days before symptom onset. 13 Vaccination status was dichotomized to either non vaccinated or fully vaccinated as per each vaccine's protocol. Vaccinated index cases defined as having been vaccinated 21 days or more prior to testing positive for COVID-19 based on evidence of the time needed for the vaccine to provide a sufficient level of immunity. Non-vaccinated index cases were defined as not having received a vaccine prior to testing positive. Households where the index case received the vaccine less than 21 days before testing positive were excluded from this analysis. Most of the vaccinated index patients (93%) had received only the first dose of vaccine. Participants were classified into one of three vaccination-status groups at the time of the index case (the confirmed exposure): Unvaccinated; Recently Vaccinated Once, i.e. those vaccinated with the first vaccine dose within 0-7 days before the index infection, and Fully Vaccinated, i.e. those who were 7 or more days post the second dose by the time of the confirmed exposure. To define the vaccine status of the household contacts, they used the test date of the primary case and compared it with the contacts vaccination dates: 1.Unvaccinated: A contact was considered unvaccinated if the primary case's test date is before the contact's first dose. 2.Partially vaccinated: A contact was considered partially vaccinated if he/she had received 1 dose of vaccine (mRNA Vaccines or AstraZeneca vaccine) prior to the test date of his/her primary case. Contacts who had received dose 2 within the last week before the primary case's test date were also considered partly vaccinated. 3.Fully vaccinated: A contact was considered fully vaccinated if he/she had received dose 2 (mRNA) at least 1 week prior to the test date of his/her primary case. 4.Booster vaccinated: A contact was considered booster vaccinated if he/she had received dose 3 at least 1 week prior to the test date of his/her primary case. The time interval between the second and the third doses should be >= 120 days. The vaccine status of the primary cases was defined based on their test date and their vaccination dates. Individuals with J&J vaccine were excluded from the study. We excluded households where two individuals tested positive on the same day to ensure a unique index case in each household. Cases were considered vaccinated if their infection occurred >7 days after the 2nd dose. Similarly, household contacts were considered vaccinated if their exposure to the index case occurred >7 days after the 2nd dose Martínez-Baz et al. 34 A person was considered fully vaccinated ≥ 14 days after receiving one dose of Janssen or the second dose of other vaccines, and partially vaccinated ≥ 14 days after receiving only the first dose of Spikevax, Comirnaty or Vaxzevria. Meyer et al. 36 Not defined, but the two secondary cases found among household contacts of vaccinated index cases were diagnosed 25 days after the second vaccination. Both index cases and close contacts were considered partially vaccinated if they had received one vaccine dose before the day the quarantine order was issued, or were within 14 days of the second dose on the day the quarantine order was issued. If more than 14 days had elapsed after their second dose, they were taken to be fully vaccinated. Partially vaccinated patients were defined as patients who received at least 1 dose of vaccine but were not fully vaccinated. Fully vaccinated patients were defined as patients who had received a second mRNA vaccine dose or a single-dose viral vector vaccine ≥14 days from symptom onset or collection of a positive specimen Singanayagam et al. 48 Participant defined as unvaccinated if they had not received a single dose of a COVID-19 vaccine at least 7 days before enrolment, partially vaccinated if they had received one vaccine dose at least 7 days before study enrolment, and fully vaccinated if they had received two doses of a COVID-19 vaccine at least 7 days before study enrolment. Effect of Vaccination on Household Transmission of SARS-CoV-2 in England Secondary household transmission of SARS-CoV-2 among children and adolescents: Clinical and epidemiological aspects SARS-CoV-2 B. 1.1. 529 (Omicron) Variant Transmission Within Households-Four US Jurisdictions Age-dependent effects on infectivity and susceptibility to SARS-CoV-2 infection: results from nationwide contact tracing data in Greece Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease Reasons for SARS-CoV-2 infection in children and their role in the transmission of infection according to age: a case-control study Complementation of contact tracing by mass testing for successful containment of beta COVID-19 variant (SARS-CoV-2 VOC B. 1.351) epidemic in Hong Kong. The Lancet Regional Health-Western Pacific Household transmission of SARS-CoV-2 from children and adolescents Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands Secondary Attack Rates, Transmission, Incubation and Serial Interval Periods of first SARS-CoV-2 Omicron variant cases in a northern region of Spain SARS-CoV-2 B. 1.617. 2 (Delta) variant COVID-19 outbreak associated with a gymnastics facility-Oklahoma High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition Is Associated With Individual Exposure but Not Community-Level Transmission BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of COVID-19 Patients COVID-19 transmission dynamics among close contacts of index patients with COVID-19: a population-based cohort study in Zhejiang province, China Increased Transmissibility of SARS-CoV-2 Alpha Variant (B.1.1.7) in Children: Three Large Primary School Outbreaks Revealed by Whole Genome Sequencing in the Netherlands Transmission dynamics of the Delta variant of SARS-CoV-2 infections in South Korea Secondary Attack Rate among the Contacts of COVID-19 Patients at the Beginning of the Pandemic in Pune City of Western Maharashtra, India Increased household transmission and immune escape of the SARS-CoV-2 Omicron variant compared to the Delta variant: evidence from Norwegian contact tracing and vaccination data Transmission dynamics and epidemiological characteristics of Delta variant infections in China Secondary attack rate of COVID-19 among contacts and risk factors Impact of BNT162b2 vaccination and isolation on SARS-CoV-2 transmission in Israeli households: an observational study Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 to Close Contacts, China Pediatric Household Transmission of Severe Acute Respiratory Coronavirus-2 Infection-Los Angeles County Transmission of SARS-CoV-2 among children and staff in German daycare centers: results from the COALA study Effect of Vaccination on Household Transmission of SARS-CoV-2 Delta VOC SARS-CoV-2 Omicron VOC Transmission in Danish Households Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households Contact tracing period and epidemiological characteristics of an outbreak of the SARS-CoV-2 Delta variant in Guangzhou Latino Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts Factors influencing the acquisition of COVID infection among high-risk contacts of COVID-19 patients in Madurai district-A case control study Two doses of the mRNA BNT162b2 vaccine reduce severe outcomes, viral load and secondary attack rate: evidence from a SARS-CoV-2 Alpha outbreak in a nursing home in Germany Transmission of SARS-CoV-2 in the household setting: A prospective cohort study in children and adults in England COVID-19 Variants Update Investigating SARS-CoV-2 transmission among co-workers in a University of Northern Italy during COVID-19 pandemic: an observational study. La Medicina del Lavoro | Work, Environment and Health Household transmission of SARS-CoV-2: a prospective observational study in Bosnia and Herzegovina Impact of Delta Variant and Vaccination on SARS-CoV-2 Secondary Attack Rate Among Household Close Contacts. The Lancet Regional Health-Western Pacific Risk factors associated with household transmission of SARS-CoV-2 in Negeri Sembilan Secondary Attack Rate among Non-Spousal Household Contacts of Coronavirus Disease Dynamics of transmission of COVID-19 cases and household contacts: A prospective cohort study Household transmission of COVID-19 among the earliest cases in Antananarivo, Madagascar. Influenza Other Respir Viruses Risk of Secondary Household Transmission of COVID-19 from Health Care Workers in a Contact tracing outcomes among household contacts of fully vaccinated COVID-19 patients Community transmission and viral load kinetics of the SARS-CoV-2 delta (B. 1.617. 2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet Infectious Diseases Multistate outbreak of SARS-CoV-2 B. 1.1. 529 (Omicron) variant infections among persons in a social network attending a convention Serial Intervals and Household Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021. Emerg Infect Dis Household Severe Acute Respiratory Syndrome Coronavirus 2 Transmission and Children: A Network Prospective Study Increased transmissibility of the SARS-CoV-2 alpha variant in a japanese population COVID-19 outbreak in Islamabad resulting from a travel-associated primary case: A case series Transmissibility of SARS-CoV-2 variants as a secondary attack in Thai households: a retrospective study SARS-CoV-2 Delta Variant Breakthrough Infection and Onward Secondary Transmission in Household Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color Increased transmissibility of SARS-CoV-2 lineage B.1.1.7 by age and viral load SARS-CoV-2 Transmission Dynamics in Households With Children Bounds on the total number of SARS-CoV-2 infections: The link between severeness rate, household attack rate and the number of undetected cases COVID-19 transmission in group living environments and households Risk Factors, Epidemiological and Clinical Outcome of Close Contacts of COVID-19 Cases in a Tertiary Hospital in Southern India A case-control study of determinants for COVID-19 infection based on contact tracing in Dungun district, Terengganu state of Malaysia Epidemiological Characteristics of COVID-19 Outbreak at Fitness Centers in Cheonan Analysis of asymptomatic and presymptomatic transmission in SARS-CoV-2 outbreak, Germany, 2020. Emerging infectious diseases Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. The Lancet Infectious Diseases Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series. The Lancet Infectious Diseases New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects Active monitoring of persons exposed to patients with confirmed COVID-19-United States Contribution of Serological Rapid Diagnostic Tests to the Strategy of Contact Tracing in Households Following SARS-CoV-2 Infection Diagnosis in Children Analysis of SARS-CoV-2 transmission in different settings, Brunei. Emerging infectious diseases Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children Loss of Taste and Smell as Distinguishing Symptoms of COVID-19 Clustering of SARS-CoV-2 infections in households of patients diagnosed in the outpatient setting in Baltimore, MD. Open Forum Infectious Diseases Case-Control Study of Use of Personal Protective Measures and Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection The first 2 months of COVID-19 contact tracing in the Northern Territory of Australia Contact tracing during Phase I of the COVID-19 pandemic in the Province of Trento, Italy: key findings and recommendations. medRxiv Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort Transmission of SARS-COV-2 infections in households-Tennessee and Wisconsin Outbreak investigation: transmission of COVID-19 starting from a spa facility in a local community in Korea Household Transmission but without the Community-acquired Outbreak of COVID-19 in Taiwan Retrospective study identifies infection related risk factors in close contacts during COVID-19 epidemic Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China Epidemiological features and viral shedding in children with SARS-CoV-2 infection Transmission Dynamics and Contact Tracing Assessment of COVID-19 in Chattogram, Bangladesh and Potential Risk of Close Contacts at Different Exposure Settings. Bangladesh and Potential Risk of Close Contacts at Different Exposure Settings Transmission of COVID-19 and its Determinants among Close Contacts of COVID-19 Patients Running title Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. The Lancet Infectious Diseases Role of children in household transmission of COVID-19. Archives of Disease in Childhood Covid-19 National Emergency Response Center Epidemiology Case Management Team Korea Centers for Disease Control Prevention. Coronavirus Disease-19: Summary of 2,370 Contact Investigations of the First 30 Cases in the Republic of Korea. Osong Public Health Res Perspect Transmission Dynamics of SARS-CoV-2 during an Outbreak in a Roma Community in Thessaly, Greece-Control Measures and Lessons Learned The characteristics of household transmission during COVID-19 outbreak in Okinawa Epidemiology and transmission dynamics of COVID-19 in two Indian states Household transmission of SARS-CoV-2 in the United States Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. The Lancet Infectious Diseases Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing. Emerging Microbes & Infections SARS-CoV-2 variant B. 1.1. 7 susceptibility and infectiousness of children and adults deduced from investigations of childcare centre outbreaks Transmission dynamics of COVID-19 in household and community settings in the United Kingdom Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China: A Prospective Cohort Study. Annals of internal medicine COVID-19 Transmission Within Danish Households: A Nationwide Study from Lockdown to Reopening. medRxiv Effectiveness of contact tracing and quarantine on reducing COVID-19 transmission: a retrospective cohort study Household Transmission of SARS-CoV-2 Familial Clusters of Coronavirus Disease in 10 Prefectures SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study. The Lancet Infectious Diseases Coronavirus Disease Outbreak in Call Center Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020. Emerging Infectious Diseases Estimation of secondary household attack rates for emergent spike L452R SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco Epidemiology of COVID-19 in Northern Ireland Outbreak Investigation of Coronavirus Disease (COVID-19) among Islamic Missionaries in Southern Thailand Assessing testing strategies and duration of quarantine in contact tracing for SARS-CoV-2: a retrospective study of San Francisco's COVID-19 contact tracing program COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence The secondary transmission pattern of COVID-19 based on contact tracing in Rwanda Epidemiology of coronavirus disease 2019 in Yamagata Prefecture Epidemiological characteristics of and containment measures for coronavirus disease Household Secondary Attack Rate in Gandhinagar district of Gujarat state from Western India Low secondary transmission rates of SARS-CoV-2 infection among contacts of construction laborers at open air environment COVID-19 contact tracing in a tertiary care hospital: A retrospective chart review Secondary attack rates of COVID-19 in Norwegian families: a nation-wide register-based study On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases. Hypothesis and Theory. Frontiers in Microbiology SARS-CoV-2 contact tracing among disadvantaged populations during epidemic intervals should be a priority strategy: results from a pilot experiment in Barcelona Nederlands tijdschrift voor geneeskunde Transmission of SARS-CoV-2 within households: a prospective cohort study in the Netherlands and Belgium -Interim results Basic epidemiological parameter values from data of real-world in mega-cities: the characteristics of COVID-19 in Beijing, China Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China Secondary attack rate of COVID-19 in household contacts in the Winnipeg Health Region Household Transmission of SARS-CoV-2 Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2 Risk of SARS-CoV-2 infection among contacts of individuals with COVID-19 in Hangzhou Risk factors associated with occurrence of COVID-19 among household persons exposed to patients with confirmed COVID-19 in Qingdao Municipal, China. Transboundary and emerging diseases Household Transmission of SARS-CoV-2 from Adults to Children Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China. Emerging Infectious Diseases Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis COVID-19 secondary attack rate and risk factors in household contacts in Castellon (Spain): Preliminary report Characterization and evolution of infection control practices among SARS-CoV-2 infected healthcare workers of acute care hospitals and long-term care facilities in Quebec, Canada New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection Burden of illness in households with SARS-CoV-2 infected children Household secondary attack rate of COVID-19 by household size and index case characteristics Follow-up investigation of asymptomatic COVID-19 cases at diagnosis in Busan The household secondary attack rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a rapid review